The six vulval precursor cells (VPCs) P3.p through P8.p are equivalent in their potential to adopt one of three vulval cell fates that are specified by the anchor cell signal. VPCs are connected to each other and to
hyp7 through adherens junctions that stain with the MH27 antibody, while Pn.p cells that do not belong to the vulval equivalence group loose their adherens junctions and fuse with
hyp7 during the first larval stage. We are interested in the role of the
apr-1 gene in vulval development.
apr-1 encodes a protein similar to the human Adenomatous Polyposis Colon tumor suppressor APC. APR-1 co-localizes with the MH27 antigen at the adherens junctions of the VPCs, the seam cells and the lateral hypodermis of the embryo. Since RNAi experiments have indicated that loss of
apr-1 function causes an embryonic lethal phenotype (C. Rocheleau et al., Cell 90:707-716 (1997)), we have specifically down regulated APR-1 expression in the VPCs by expressing antisense
apr-1 cDNA under control of the Pn.p cell-specific
lin-31 promoter. VPCs expressing antisense
apr-1 RNA exhibit no detectable APR-1 staining, lack adherens junctions in 53% of the cases (n=114) and adopt an undivided, non-vulval cell fate in 70% of the cases (n=30), resulting in an 80% penetrant vulvaless phenotype. Mutations in the beta-catenin/armadillo related gene
bar-1 and in the HOX gene
lin-39 cause a similar phenotype, and APR-1 specifically interacts with BAR-1 in a yeast two-hybrid assay. These observations have suggested two possible models: (1) APR-1 might act together with BAR-1 to specify the vulval equivalence group by inducing
lin-39 expression in the VPCs, or (2) APR-1 might be required to maintain the adherens junctions and thus prevent the VPCs from fusing with
hyp7 before the vulva is induced.